Is JVInvest stock valuation data free and transparent?

Yes, all valuation data on JVInvest is 100% free and transparent. We provide verifiable P/E ratios for the Top 100 global stocks, S&P 500, Nasdaq 100, and major indices worldwide. All data sources are disclosed so you can verify every calculation yourself.

What valuation metrics are available on JVInvest?

JVInvest provides transparent P/E ratios for Top 100 global stocks (MSCI World), S&P 500, Nasdaq 100, DAX, FTSE 100, Nikkei 225 and more. All valuation metrics are verifiable with disclosed quarterly EPS data and market prices.

Do I need to create an account to access the data?

No account or signup is required. All S&P 500 fundamental data is freely accessible without registration.

How can I verify the P/E ratio calculations?

All our valuation data is 100% transparent. We disclose all data sources, quarterly EPS figures, and market prices used in calculations. You can verify every P/E ratio yourself using our transparent methodology.

What is a Sankey chart for stocks?

A Sankey chart visualizes the flow of money through a company's financial statements - showing how revenue flows to costs, operating income, net income, and cash flows. JVInvest offers free Sankey charts for all S&P 500 companies.

Which stock indices have free valuation data?

JVInvest provides free, verifiable valuation data for major global indices: S&P 500, Nasdaq 100, DAX 40, FTSE 100, CAC 40, Nikkei 225, and the Top 100 MSCI World stocks. All index P/E ratios are calculated transparently.

What is the current S&P 500 P/E ratio?

JVInvest calculates and displays the current S&P 500 index P/E ratio based on the aggregate earnings of all constituent companies. Visit the Valuation page for the latest P/E ratio data.

Daily Market Report – July 9, 2026

Name: Transparent Stock Valuation Data (English & German)
Creator: JVInvest
License: https://creativecommons.org/licenses/by/4.0/

Markets The S&P 500 (SPX) is trading at 7,533 points, an increase of 0.68 percent, while the Nasdaq 100 (NDX) rose by 1.51 percent to 29,693 points. The Dow Jones (DJI) is up by 0.41 percent at 52,561 points. In Europe, the DAX (DAX) closed 0.89 percent higher at 25,118 points and the Euro Stoxx 50 (SX5E) recorded an increase of 1.28 percent to 6,284 points. In the Asian market, the 225 (NI225) closed with a gain of 1.38 percent at 67,744 points, while the Hang Seng (HSI) fell by 0.70 percent to 24,030 points and the Shanghai Composite (000001) rose by 1.16 percent to 4,037 points. The yield on ten-year U.S. Treasury bonds (US10Y) decreased by 0.48 percent to 4.55 percent.

Company The stocks of the semiconductor industry recorded significant gains, driven by positive sentiment and optimistic assessments regarding demand development. Micron Technology (MU) was among the biggest winners in the sector, with an increase of 7.24 percent to $1,017.54. Similarly, Lam Research (LRCX) rose by 7.03 percent to $356.56. Advanced Micro Devices (AMD) also benefited, climbing 6.87 percent to $552.98. Applied Materials (AMAT) gained 6.75 percent, trading at $609.00, while KLA (KLAC) increased by 6.50 percent to $235.55. The South Korean memory chip manufacturer SK Hynix (000660) also recorded a remarkable price development with an increase of 5.30 percent to 2,186,000 won. This broad upward movement in the semiconductor sector reflects the persistently high demand for chips and equipment for data centers as well as in the field of artificial intelligence. In contrast, the shares of AstraZeneca (AZN) fell by 5.35 percent to 179.15 British pounds. Market participants took profits after the stock had significantly risen over the weeks. Investors apparently reassessed the business prospects of several pharmaceutical companies. Some analysts lowered their price targets for several biotechnology and pharmaceutical companies, leading to a broader correction in the sector. Furthermore, uncertainties regarding future drug approvals and patent expirations weighed on sentiment. The shares of other major pharmaceutical companies such as Novartis and Sanofi also showed weakness, albeit to a lesser extent. The market is looking ahead to the upcoming IPO of SK hynix on Nasdaq on Friday, which is considered one of the largest capital market transactions in recent years. The issuance of the American Depositary Shares faced very high demand and was reportedly oversubscribed multiple times. The US listing will broaden the international investor base and help reduce the valuation discount compared to American semiconductor companies like Micron or Nvidia (NVDA).

Macroeconomics Investor attention continued to focus on developments in Iran and the commodity markets. The declining oil prices were reflected in the drop of WTI crude oil by 1.85 percent to $72.16 per barrel and Brent crude oil by 1.79 percent to $76.62 per barrel. The price of natural gas also fell significantly by 5.92 percent to $3.02 per million British Thermal Units. At the same time, precious metals such as gold and silver saw significant price increases. Gold rose by 1.43 percent, while silver increased by 3.99 percent.

*Report for Trading Day 07.09.2026 · Created on 07.09.2026 / 12:23 (ET)*